Evaluating the cytotoxicity of flaxseed orbitides for potential cancer treatment
Оценка цитотоксичности орбитидов льняного семени для потенциального лечения рака
2015-01-01
SCID: 54.1/a3cjkct9
Discuss with AI
breast cancer cell linescytotoxicityflaxseed orbitideslinoorbitides (LOBs)melanoma A375 cells
Figures from the paper
Abstract (AI)
Flaxseed as well as its oil component possess antitumor activities against different types of cancer and have been used by some patients as complementary and/or alternative medicine. Linoorbitides (LOBs) are one family of flaxseed compounds that has implications for anticancer and antioxidant activity . The cytotoxicity of [1-9-NαC]-linusorb-B3 (LOB3), [1-9-NαC]-linusorb-B2 (LOB2), [1-9-NαC],[1-R s ,S s -MetO]-linusorb-B2 ([MetO]-LOB2) and [1-8-NαC],[1-R s ,S s -MetO]-linusorb-B1 ([MetO]-LOB1) was measured against human breast cancer Sk-Br-3 and MCF7 cell lines and melanoma A375 cell line. Overall cytotoxicity is cell-type specific. It scales as the hydrophobicity and concentration of the LOBs with the most abundant LOB3 being the most cytotoxic. Oral administration of LOB3 as a potential therapeutic agent might not be applicable as a much too high and/or frequent dose would be required to achieve a serum concentration of 400–500 μg/mL due to bioavailability and pharmacokinetic factors. However, LOB3 may be suitable for topical treatment formulations or as a lead compound in developing anticancer LOB derivatives.
Key Findings
1
Four flaxseed linoorbitides (LOB3, LOB2, MetO-LOB2, and MetO-LOB1) were evaluated for cytotoxicity against human breast cancer Sk-Br-3 and MCF7 cells and melanoma A375 cells.
2
LOB3 may be more suitable for topical formulations or as a lead compound for developing anticancer linoorbitide derivatives.
3
LOB3, the most abundant linoorbitide, showed the greatest cytotoxicity among the compounds tested.
4
Linoorbitide cytotoxicity was cell-type specific and increased with both compound hydrophobicity and concentration.
5
Oral LOB3 therapy may be impractical because bioavailability and pharmacokinetics would require excessively high or frequent dosing to reach serum concentrations of 400–500 μg/mL.
Research Object
Flaxseed linoorbitides (LOBs)—LOB3, LOB2, [MetO]-LOB2, and [MetO]-LOB1—in human breast cancer and melanoma cell lines
Research Subject
Cell-type-specific cytotoxicity of the linoorbitides, including its dependence on hydrophobicity and concentration, and the therapeutic applicability of LOB3
Publication Details
Publication Date
2015-01-01
Journal
Publisher
ISSN
Cited by
44
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest